n
known
play
import
role
tumour
cell
invas
examin
whether
basic
fibroblast
growth
factor
bfgf
involv
regul
express
human
melanoma
cell
human
melanoma
cell
stabli
transfect
construct
encod
either
kda
bfgf
isoform
protein
observ
highli
increas
mrna
protein
express
clone
regardless
overexpress
either
isoform
protein
neutral
aminopeptidas
activ
increas
fivefold
could
inhibit
bestatin
antibodi
enhanc
invas
matrigel
migrat
wound
assay
effici
abrog
bestatin
upregul
express
result
increas
epitheli
myeloid
promot
activ
clone
interestingli
panel
human
melanoma
cell
line
signific
correl
r
bfgf
mrna
protein
express
detect
high
bfgf
express
clearli
relat
aggress
phenotyp
taken
togeth
data
indic
high
bfgf
express
upregul
express
human
melanoma
cell
activ
myeloid
epitheli
promot
addit
show
high
bfgf
express
result
enhanc
invas
capac
metastat
behaviour
human
melanoma
cell
cutan
melanoma
type
skin
cancer
high
metastat
potenti
melanoma
cell
express
wide
varieti
angiogen
growth
factor
basic
fibroblast
growth
factor
bfgf
vascular
endotheli
growth
factor
vegf
plateletderiv
growth
factor
pdgf
tumour
develop
melanoma
cell
depend
autocrin
product
growth
factor
prolifer
surviv
rodeck
halaban
specif
bfgf
appear
key
signal
melanoma
progress
basic
fibroblast
growth
factor
involv
prolifer
migrat
invas
tumour
cell
bikfalvi
et
al
report
bfgf
overexpress
human
melanoma
cell
respons
upregul
result
highli
increas
invas
capac
n
zn
depend
type
transmembran
ectopeptidas
kda
form
noncoval
bound
homodim
cellular
membran
although
first
describ
marker
haematopoiet
cell
myeloid
origin
express
report
nonhaematopoiet
cell
tissu
fibroblast
brain
cell
epitheli
cell
liver
kidney
intestin
ctermin
part
protein
locat
extracellularli
contain
activ
site
riemann
et
al
preferenti
cleav
neutral
amino
acid
small
peptid
rather
larg
protein
broad
substrat
specif
function
role
strongli
depend
locat
express
previou
studi
indic
intestin
involv
termin
degrad
small
peptid
aminoacid
scaveng
turner
synapt
membran
brain
shown
inactiv
endorphin
enkephalin
matsa
et
al
addit
particip
process
peptid
present
major
histocompat
complex
class
ii
molecul
hansen
et
al
larsen
et
al
furthermor
act
receptor
transmiss
gastroenter
viru
human
coronaviru
delma
et
al
high
express
detect
number
human
solid
tumour
includ
melanoma
menrad
et
al
saiki
et
al
fujii
et
al
ishii
et
al
hashida
et
al
ikeda
et
al
kehlen
et
al
van
hensbergen
et
al
solubl
form
shown
highli
increas
intratumor
fluid
ascit
van
hensbergen
et
al
observ
done
regard
function
role
malign
melanoma
cell
report
act
auxiliari
adhes
molecul
transloc
site
cell
cell
contact
menrad
et
al
renal
cell
carcinoma
fibrosarcoma
melanoma
cell
line
facilit
invas
degrad
extracellular
matrix
ecm
menrad
et
al
saiki
et
al
fujii
et
al
also
involv
tumour
angiogenesi
sinc
present
tumour
endotheli
cell
exist
blood
vessel
normal
tissu
pasqualini
et
al
menrad
et
al
first
describ
presenc
melanoma
cell
wherea
express
could
detect
normal
melanocyt
moreov
express
becom
increasingli
preval
process
melanoma
progress
elder
et
al
menrad
et
al
directli
associ
ecm
degrad
invas
transfect
human
melanoma
cell
result
increas
degrad
type
iv
collagen
invas
ecm
suggest
may
serv
activ
type
iv
collagenas
requir
invas
metastat
phenotyp
melanoma
cell
fujii
et
al
express
regul
two
distinct
cell
typespecif
promot
proxim
epitheli
promot
distal
myeloid
promot
epitheli
promot
mainli
activ
epitheli
cell
intestin
kidney
liver
brain
endotheli
cell
myeloid
promot
activ
monocyt
myeloid
leukaemia
cell
fibroblast
shapiro
et
al
two
promot
regul
differ
transcript
factor
transcript
result
express
protein
addit
promot
thought
activ
mutual
exclus
manner
shapiro
et
al
endotheli
cell
mrna
protein
express
transcript
upregul
respons
divers
factor
influenc
tumour
microenviron
hypoxia
increas
presenc
angiogen
growth
factor
bfgf
vegf
tumour
necrosi
factor
tnfa
insulinlik
growth
bhagwat
et
al
upregul
endotheli
cell
shown
mediat
activ
proxim
promot
regul
melanoma
cell
remain
determin
recent
observ
overexpress
bfgf
human
melanoma
cell
result
acceler
vitro
vivo
growth
rate
clone
display
differ
morpholog
suggest
chang
express
adhes
molecul
fontijn
et
al
unpublish
data
sinc
implic
melanoma
invas
determin
whether
protein
upregul
bfgfoverexpress
clone
report
bfgf
induc
express
human
melanoma
cell
result
highli
increas
invas
capac
addit
report
promot
activ
upon
upregul
bfgf
furthermor
found
strong
correl
bfgf
express
panel
human
melanoma
cell
line
human
melanoma
cell
line
blm
kind
gift
dr
jr
westphal
dr
w
leender
univers
medic
centr
st
radboud
nijmegen
netherland
establish
surgic
remov
melanoma
metastas
van
muijen
et
al
bro
cell
line
deriv
highli
malign
aggress
primari
melanoma
lockshin
et
al
human
hepatocellular
carcinoma
cell
human
promyelocyt
leukaemia
cell
human
histiocyt
lymphoma
cell
obtain
american
type
cultur
collect
atcc
manassa
va
usa
cell
line
clone
highli
h
lowli
l
overexpress
isoform
human
bfgf
isoform
bfgf
control
empti
vector
cell
describ
fontijn
et
al
unpublish
data
cell
cultur
dulbecco
modifi
eagl
medium
dmem
bio
whittak
vervier
belgium
supplement
heatinactiv
fetal
calf
serum
fc
gibco
invitrogen
breda
netherland
u
ml
penicillin
icn
biochem
zoeterm
netherland
mg
ml
streptomycin
icn
biochem
addit
bfgfoverexpress
clone
cultur
presenc
mg
ml
geneticin
gibcoinvitrogen
maintain
select
bfgf
overexpress
cell
grown
humidifi
air
contain
co
total
rna
cell
line
isol
use
trizol
reagent
gibco
invitrogen
accord
manufactur
protocol
rna
mg
reversetranscrib
u
mmlv
revers
transcriptas
invitrogen
presenc
ml
mg
ml
random
primer
quantit
light
cycler
rt
pcr
use
determin
bfgf
mrna
melanoma
cell
bfgfoverexpress
clone
van
hensbergen
et
al
mrna
analys
lightcyclerfaststart
dna
master
hybrid
probe
ksybr
green
kit
roch
diagnost
mannheim
germani
human
bfgf
sens
antisens
sens
gtaatacgactcact
antisens
aatta
intern
control
human
sens
gatgagta
antisens
gapdh
sens
antisens
pdgb
sens
tccaa
antisens
agaatcttgtcccctgtgg
gene
amplifi
accord
manufactur
protocol
short
reaction
mix
contain
mm
mgcl
mm
sens
antisens
primer
faststart
dna
master
sybr
green
mix
contain
lightcyclerfaststart
enzym
faststart
taq
dna
polymeras
sybr
green
dye
dntp
reaction
buffer
ml
cdna
polymeras
chain
reaction
condit
follow
min
follow
cycl
cdna
replac
pcrgrade
water
neg
control
rel
express
level
differ
sampl
calcul
bfgf
cross
point
normalis
rel
mrna
express
calcul
e
dcp
target
gene
e
dcp
refer
gene
e
effici
dcp
cross
point
compar
cell
primer
effici
determin
use
pool
cdna
experi
design
investig
effect
bfgf
overexpress
mrna
stabil
cell
made
quiescent
serumfre
medium
h
next
cell
preincub
mg
ml
actinomycin
sigmaaldrich
chemi
zwijndrecht
netherland
h
serumfre
medium
time
point
h
thereaft
harvest
incub
h
mg
ml
actinomycin
serumfre
medium
time
point
mrna
level
determin
light
cycler
rt
pcr
express
fragment
deriv
activ
myeloid
mp
myeloid
epitheli
mpep
promot
determin
rt
pcr
total
ml
cdna
subject
pcr
cycl
sens
primer
mp
agtcca
mpep
atggccaagggct
share
antisens
primer
mpep
ac
intern
control
express
detect
sampl
polymeras
chain
reaction
condit
follow
min
hotstart
follow
denatur
step
anneal
elong
amplif
product
separ
agaros
gel
contain
mg
ml
ethidium
bromid
invitrogen
analys
qualit
way
use
geldoc
system
biorad
laboratori
veenenda
netherland
melanoma
cell
line
bfgfoverexpress
clone
lyse
icecold
fosripa
lysi
buffer
mm
trishcl
mm
nacl
sd
sodium
deoxychol
supplement
mm
trypsin
inhibitor
sigmaaldrich
mg
ml
leupeptin
sigmaaldrich
mm
pmsf
merck
amsterdam
netherland
mm
sodium
ortho
vanad
sigmaaldrich
mm
sodium
fluorid
baker
chemic
devent
netherland
min
ice
lysat
centrifug
min
rpm
remov
debri
protein
concentr
cell
lysat
measur
accord
bradford
protein
denatur
addit
sampl
buffer
contain
bmercapto
ethanol
incub
min
protein
subject
sd
page
polyacrylamid
gel
electrophoret
transfer
polyvinyliden
difluorid
membran
immobilon
millipor
ettenleur
netherland
membran
block
h
tbst
mm
tri
ph
mm
l
nacl
tween
milk
incub
overnight
mg
ml
rabbit
polyclon
human
bfgfdirect
antiserum
santa
cruz
biotechnolog
heerhugowaard
netherland
mg
ml
mous
polyclon
human
antiserum
santa
cruz
biotechnolog
milk
wash
tbst
bfgf
membran
incub
h
room
temperatur
respect
horseradish
peroxidaseconjug
mous
antirabbit
igg
dilut
cell
signal
technolog
heerhugowaard
netherland
horseradish
peroxidaseconjug
rabbit
antimous
igg
dilut
dako
cytom
heverle
netherland
milk
membran
wash
protein
visual
electrochemiluminesc
cell
confluenc
harvest
short
trypsinis
wash
resuspend
phosphatebuff
salin
pb
contain
bovin
serum
albumin
bsa
nano
cell
incub
room
temperatur
min
dilut
phycoerythrin
pe
conjug
antihuman
monoclon
antibodi
bd
bioscienc
alphen
aanden
rijn
netherland
peconjug
mous
pb
cell
wash
analys
fac
calibur
flow
cytomet
bd
bioscienc
result
express
ratio
mean
fluoresc
divid
surfac
aminopeptidas
activ
measur
plate
cell
serum
plate
accord
van
hensbergen
et
al
incub
period
medium
remov
fresh
serumfre
medium
contain
bsa
ad
h
cell
wash
pb
incub
ml
alanineamc
trifluoroacet
sigmaaldrich
absenc
presenc
mm
bestatin
sigmaaldrich
mg
ml
mous
monoclon
antibodi
bd
bioscienc
releas
fluoresc
product
monitor
everi
min
h
spectrafluor
multipl
reader
tecan
salzburg
austria
excit
wavelength
l
nm
emiss
wavelength
l
nm
neutral
aminopeptidas
activ
calcul
slope
fluoresc
time
curv
use
calibr
curv
sigmaaldrich
cell
seed
plate
grown
confluenc
wound
scratch
confluent
cell
layer
steril
pipett
tip
two
direct
medium
replac
medium
without
mg
ml
mous
igg
mg
ml
mm
bestatin
immedi
wound
time
point
h
wound
photograph
magnif
confoc
laserscan
microscop
leica
tc
leica
jena
germani
video
camera
attach
comput
leica
softwar
leica
width
wound
measur
four
area
time
point
compar
origin
wound
time
point
h
possibl
toxic
igg
bestatin
determin
perform
parallel
mtt
bromid
sigmaaldrich
assay
mosmann
use
four
replic
well
exposur
time
h
cell
growth
untreat
cell
set
growth
treat
cell
express
percentag
control
cell
growth
matrigel
invas
assay
perform
plate
transwel
system
van
hensbergen
et
al
filter
mm
pore
size
ht
fluoroblok
insert
becton
dickinson
labwar
le
pont
de
claix
franc
coat
lower
side
fibronectin
merck
h
wash
pb
coat
upper
side
filter
matrigel
mg
filter
sigmaaldrich
dmem
contain
fc
ad
lower
compart
cell
dmem
contain
fc
volum
ml
ad
upper
compart
control
well
fc
ad
lower
upper
compart
inhibit
invas
mm
bestatin
ad
upper
lower
compart
ml
present
upper
compart
includ
preincub
period
cell
seed
cell
allow
invad
h
invas
quantifi
expos
cell
lower
compart
mm
calceinam
molecular
probe
leiden
netherland
final
min
assay
calceinam
acetoxymethyl
ester
calcein
diffus
readili
cell
membran
cytosol
calceinam
convert
fluorochrom
calcein
esteras
calcein
fluoresc
lower
compart
measur
spectrafluor
multipl
reader
tecan
excit
wavelength
l
nm
emiss
wavelength
l
nm
cytotox
bestatin
determin
perform
parallel
mtt
assay
exposur
time
h
similar
way
describ
migrat
assay
promoterluciferas
report
construct
bstxiluciferas
encod
epitheli
promot
encod
myeloid
promot
kind
gift
dr
lh
shapiro
describ
previous
bhagwat
et
al
basicluciferas
prenilla
luciferasecmv
purchas
promega
leiden
netherland
exponenti
grow
cell
bfgfoverexpress
clone
duplic
well
sixwel
plate
transient
transfect
mg
report
plasmid
h
use
fugen
transfect
reagent
roch
diagnost
follow
manufactur
protocol
cotransfect
ng
prenilla
luciferasecmv
prlcmv
perform
correct
possibl
differ
transfect
effici
activ
firefli
renilla
luciferas
determin
dual
luciferas
report
assay
promega
follow
manufactur
protocol
short
cell
lyse
scrape
presenc
ml
passiv
lysi
buffer
total
ml
cell
lysat
transfer
luminomet
tube
contain
ml
lar
ii
buffer
promega
firefli
luciferas
activ
measur
consecut
renilla
luciferas
activ
measur
ad
ml
stop
glo
reagent
promega
rel
promot
activ
cell
bfgftransfect
clone
calcul
formula
firefli
luciferas
cmv
renilla
luciferas
basic
firefli
luciferas
cmv
renilla
luciferas
statist
analysi
possibl
differ
mean
valu
perform
twotail
student
ttest
consid
signific
recent
characteris
melanoma
cell
stabli
transfect
isoform
bfgf
isoform
bfgf
control
empti
vector
fontijn
et
al
unpublish
data
overexpress
bfgf
biolog
activ
human
umbil
vein
endotheli
cell
huvec
prolifer
assay
chang
cell
morpholog
observ
cell
overexpress
bfgf
isoform
contrast
cell
larg
cell
numer
dendrit
cell
process
cell
appear
smaller
round
form
less
dendrit
cell
process
addit
significantli
acceler
vitro
vivo
growth
rate
respect
twoand
threefold
observ
cell
tumour
overexpress
either
bfgf
isoform
fontijn
et
al
unpublish
data
sinc
chang
morpholog
growth
rate
might
indic
increas
aggress
behaviour
determin
whether
express
upregul
bfgfoverexpress
cell
express
activ
increas
cell
overexpress
isoform
bfgf
bfgf
mrna
protein
express
cell
clone
lowli
highli
overexpress
alll
allh
isoform
bfgf
visualis
figur
increas
mrna
express
observ
well
clone
compar
express
level
figur
figur
show
mrna
express
clone
normalis
two
refer
gene
gapdh
pdgb
similar
pattern
upregul
observ
although
absolut
fold
increas
express
level
vari
refer
gene
choic
genorm
analysi
vandesompel
et
al
indic
among
refer
gene
human
gapdh
stabl
model
data
shown
high
express
bfgftransfect
clone
confirm
protein
level
western
blot
figur
fluorescenceactiv
cell
sorter
analysi
also
confirm
high
protein
express
increas
bfgfoverexpress
clone
figur
express
clone
twofold
higher
bro
cell
line
contain
high
level
endogen
test
whether
overexpress
enzymat
activ
aminopeptidaseactiv
releas
alanineamc
measur
clone
highli
overexpress
bfgf
isoform
protein
figur
line
mrna
protein
express
aminopeptidas
activ
increas
fivefold
bfgfoverexpress
clone
addit
mm
bestatin
nonspecif
aminopeptidas
inhibitor
result
inhibit
enzym
activ
cell
line
contrast
specif
antibodi
mg
ml
inhibit
enzymat
activ
cell
suggest
involv
basal
neutral
aminopeptidas
activ
cell
howev
exposur
result
threefold
reduct
total
aminopeptidas
activ
indic
increas
enzymat
activ
cell
mainli
due
increas
level
high
express
bfgfoverexpress
clone
facilit
invas
migrat
implic
requir
melanoma
cell
invas
ecm
vitro
well
vivo
menrad
et
al
fujii
et
al
therefor
determin
whether
increas
express
observ
highli
bfgfoverexpress
clone
result
higher
invas
capac
contrast
cell
show
invas
matrigel
mg
filter
presenc
fc
use
chemoattract
highli
increas
invas
observ
clone
figur
figur
show
clone
even
invad
matrigel
mg
filter
addit
mm
bestatin
result
complet
inhibit
fcsinduc
invas
exposur
mg
ml
antibodi
also
result
signific
reduct
invas
toxic
bestatin
determin
mtt
assay
bestatin
mm
result
growth
inhibit
approxim
mg
ml
affect
cell
growth
data
shown
migratori
capac
cell
bfgfoverexpress
clone
determin
wound
assay
figur
illustr
clone
clearli
higher
rate
migrat
compar
parent
cell
exposur
mg
ml
inhibit
basic
fibroblast
growth
factorinduc
express
due
increas
mrna
stabil
one
possibl
mechan
increas
express
observ
bfgfoverexpress
cell
increas
mrna
stabil
test
possibl
determin
degrad
mrna
bfgftransfect
clone
incub
transcript
inhibitor
actinomycin
differ
time
period
lightcycl
pcr
figur
seen
mrna
basic
fibroblast
growth
factor
induc
express
transcript
myeloid
promot
transcript
regul
mediat
distal
myeloid
promot
proxim
epitheli
promot
shapiro
et
al
design
primer
set
specif
detect
mrna
express
result
activ
myeloid
promot
mp
cell
includ
posit
control
myeloid
promot
activ
neg
control
cell
use
sinc
express
cell
line
result
activ
epitheli
promot
myeloid
promot
fragment
could
detect
cell
figur
lane
high
level
myeloid
promot
fragment
observ
clone
overexpress
bfgf
isoform
figur
lane
second
primer
set
mpep
use
amplifi
fragment
result
activ
epitheli
myeloid
promot
expect
posit
band
observ
cell
line
use
primer
set
rt
pcr
analysi
indic
least
myeloid
promot
involv
increas
express
observ
bfgfoverexpress
clone
examin
whether
myeloid
myeloid
epitheli
promot
activ
transient
transfect
perform
use
report
gene
construct
encod
either
myeloid
promot
bstxiluc
epitheli
promot
correct
possibl
differ
transfect
effici
parent
cell
bfgfoverexpress
clone
cotransfect
perform
prenillacmv
myeloid
promot
activ
clone
respect
aminopeptidas
activ
nmol
min
control
bestatin
figur
neutral
aminopeptidas
activ
clone
highli
overexpress
bfgf
isoform
protein
aminopeptidas
activ
determin
absenc
presenc
mm
bestatin
mg
ml
slope
fluorescencetim
curv
use
calibr
curv
express
nmol
min
mean
valu
shown
triplic
sampl
bfgf
upregul
express
melanoma
fontijn
et
al
induc
interestingli
activ
epitheli
promot
also
induc
bfgfoverexpress
clone
figur
data
clearli
indic
although
basal
activ
myeloid
promot
cell
higher
compar
activ
epitheli
promot
promot
activ
bfgfoverexpress
cell
sinc
observ
bfgf
overexpress
induc
express
human
melanoma
cell
determin
whether
correl
bfgf
mrna
express
panel
melanoma
cell
line
inde
two
cell
line
bro
blm
high
bfgf
express
also
contain
high
level
mrna
low
mrna
content
present
cell
express
low
level
bfgf
mrna
figur
significantli
posit
correl
calcul
bfgf
mrna
express
po
r
accord
mrna
data
protein
express
observ
bro
blm
cell
line
contain
high
level
bfgf
protein
figur
report
first
time
overexpress
bfgf
human
melanoma
cell
mediat
highli
increas
express
mrna
protein
indic
bfgf
involv
induct
invas
cellular
phenotyp
increas
invas
bfgfoverexpress
clone
matrigel
could
attribut
high
express
sinc
specif
monoclon
antibodi
inhibit
process
accord
effect
bfgf
overexpress
found
panel
human
melanoma
cell
line
highli
signific
correl
endogen
bfgf
mrna
express
well
spontan
metastasi
format
find
point
toward
import
role
bfgf
high
metastat
potenti
melanoma
patient
experi
made
use
cell
low
endogen
bfgf
level
transfect
vector
either
bfgf
upregul
express
melanoma
fontijn
et
al
encod
isoform
isoform
attempt
distinguish
variat
phenotyp
behaviour
induc
differ
protein
bfgf
isoform
function
autocrin
paracrin
growth
factor
mainli
found
cytoplasm
cell
bound
heparan
sulphat
proteoglycan
hspg
cell
membran
contrast
high
molecular
weight
hmw
isoform
locat
nucleu
thought
play
role
transcript
regul
renko
et
al
bugler
et
al
florkiewicz
et
al
quarto
et
al
upon
transfect
howev
clone
express
similar
amount
suggest
express
protein
alon
suffici
induct
moreov
chang
morpholog
growth
rate
similar
clone
induct
express
exogen
bfgf
previous
describ
human
endotheli
cell
requir
vasculogenesi
studi
bhagwat
et
al
addit
bfgf
protein
serumstarv
huvec
upregul
mrna
express
although
bfgf
potent
stimul
express
studi
induct
protein
also
observ
endotheli
cell
cultur
hypox
condit
treat
angiogen
growth
factor
vegf
tnfa
inhibit
express
bestatin
amastatin
monoclonalanti
antibodi
result
clear
reduct
capillari
tube
format
huvec
effect
bhagwat
et
al
author
also
report
exogen
bfgf
could
induc
express
kaposi
sarcoma
cell
bhagwat
et
al
recent
kehlen
et
al
shown
induct
express
upon
stimul
serumstarv
thyroid
carcinoma
cell
bfgf
repeatedli
abl
increas
express
stimul
serumstarv
cell
exogen
recombin
human
bfgf
regardless
effici
stimul
cell
prolifer
data
shown
find
indic
bfgfmediat
induct
cell
indirect
effect
transform
process
rather
direct
effect
promot
activ
sinc
detect
melanoma
cell
elder
et
al
menrad
et
al
fujii
et
al
first
report
endogen
bfgf
mediat
express
activ
protein
bestatin
wellknown
chemic
inhibitor
aminopeptidas
activ
block
catalyt
site
enzym
competit
manner
although
bestatin
often
consid
specif
also
inhibit
aminopeptidas
aminopeptidas
b
leucin
aminopeptidas
scornik
botbol
high
concentr
bestatin
mm
clearli
reduc
invas
fibrosarcoma
cell
melanoma
cell
matrigel
menrad
et
al
fujii
et
al
monoclon
antibodi
specif
neutralis
activ
shown
inhibit
invas
matrigel
describ
renalcel
carcinoma
fibrosarcoma
melanoma
cell
saiki
et
al
bfgfoverexpress
clone
bestatin
almost
complet
abrog
enhanc
invas
capac
observ
indic
increas
express
activ
bfgfoverexpress
clone
mainli
respons
facilit
invas
potenti
activ
myeloid
epitheli
promot
believ
mutual
exclus
shapiro
et
al
result
express
protein
particular
cell
type
thought
mediat
activ
either
myeloid
epitheli
promot
show
promot
activ
respons
bfgf
overexpress
although
cell
basal
express
myeloid
promot
consist
found
higher
activ
epitheli
promot
activ
increas
extent
fourfold
clone
know
current
result
specif
melanoma
cell
whether
use
sensit
techniqu
would
also
allow
detect
upregul
promot
cell
type
initi
promot
studi
perform
chloramphenicol
acetyl
transferas
cat
assay
northern
blot
shapiro
et
al
made
use
rt
pcr
promoterluciferas
assay
allow
us
detect
activ
promot
melanoma
cell
clone
recent
induct
express
bfgf
endotheli
cell
shown
regul
two
rasmedi
signal
pathway
implic
transit
quiescent
activ
endothelium
mitogenactiv
protein
kinas
mapk
kinaseakt
pathway
petrov
et
al
demonstr
activ
endotheli
cell
transcript
induc
rasmapkmedi
phosphoryl
transcript
factor
result
increas
activ
epitheli
promot
bfgfoverexpress
clone
phosphoakt
mapk
level
increas
compar
basal
level
parent
cell
basal
mapk
increas
fontijn
et
al
unpublish
data
investig
possibl
contribut
mapk
signal
pathway
increas
express
bfgfoverexpress
clone
gener
high
express
solid
tumour
patient
consid
unfavour
factor
clinic
studi
avail
among
observ
pancreat
carcinoma
colon
carcinoma
thyroid
carcinoma
describ
shortli
protein
express
detect
pancreat
carcinoma
patient
significantli
associ
shorter
median
surviv
ikeda
et
al
diseasefre
overal
surviv
rate
patient
colon
carcinoma
significantli
lower
patient
without
express
hashida
et
al
kehlen
et
al
shown
express
undifferenti
thyroid
carcinoma
higher
papillari
follicular
thyroid
carcinoma
suggest
marker
differenti
clinic
studi
express
cutan
melanoma
yet
carri
hypothes
presenc
melanoma
patient
also
associ
poor
prognosi
rational
shown
vitro
inhibit
aminopeptidas
activ
reduc
invas
capac
melanoma
cell
matrigel
menrad
et
al
saiki
et
al
upon
transfect
melanoma
cell
increas
degrad
type
iv
collagen
invas
ecm
observ
fujii
et
al
cell
show
significantli
augment
lungcolonis
potenti
nude
mice
fujii
et
al
observ
agreement
data
cell
could
hardli
invad
matrigel
invas
capac
greatli
facilit
case
overexpress
proof
concept
panel
human
melanoma
cell
line
found
clear
correl
bfgf
mrna
protein
express
figur
high
bfgf
protein
express
could
detect
melanoma
cell
line
bro
blm
aggress
cell
line
basi
high
vitro
vivo
growth
rate
furthermor
blm
bro
cell
grown
subcutan
xenograft
nude
mice
high
rate
spontan
metastasi
format
lockshin
et
al
van
muijen
et
al
bestatin
studi
therapeut
use
clinic
past
sinc
compound
consid
immunopotenti
activ
ota
prospect
randomis
trial
adult
nonlymphocyt
leukaemia
prolong
remiss
durat
surviv
achiev
bestatin
ad
mainten
chemotherapi
elderli
patient
ota
et
al
prospect
randomis
clinic
trial
variou
solid
tumour
contain
either
patient
neg
demonstr
benefici
effect
surviv
ota
recent
randomis
doubleblind
placebocontrol
trial
ichinos
et
al
bestatin
given
aminopeptidas
inhibit
immunostimul
antitumour
activ
patient
complet
resect
stage
squamouscel
lung
carcinoma
patient
enter
studi
appear
overal
surviv
cancerfre
surviv
significantli
differ
favour
bestatintr
group
sinc
found
clear
correl
bfgf
express
invas
melanoma
cell
incorpor
bestatin
clinic
trial
stage
ii
melanoma
patient
consid
aim
prevent
develop
metastas
improv
surviv
conclus
data
indic
high
bfgf
express
human
melanoma
cell
major
mechan
upregul
result
enhanc
invas
capac
metastat
behaviour
select
inhibit
even
bfgf
therefor
attract
strategi
treatment
advanc
melanoma
like
also
adjuv
treatment
stage
ii
diseas
